Search - tctmd.com

Displaying 81 - 100 of 617

Sort: Relevancy | Date

Presentation Miami Valves 2025

Novel TMVR Devices: CAPSTAN Medical

Presenter: Santiago Garcia

January 30, 2025

Presentation Miami Valves 2025

Luna™ TMVR: Novel 28 French Transseptal TMVR System

Presenter: Adrian Ebner

January 30, 2025

Presentation Miami Valves 2025

Investigational Transeptal TMVR: SAPIEN M3

Presenter: Santiago Garcia

January 30, 2025

Presentation Miami Valves 2025

TMVR and the Tendyne roll-in and MAC experience

Presenter: Pablo Rengifo-Moreno

January 30, 2025

Presentation Miami Valves 2025

Preventing LVOT Obstruction during TMVR: Septal reduction and LAMPOON-What does the data say?

Presenter: Pedro Villablanca

January 30, 2025

News Conference News PCR London Valves 2024

Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes

Michael O'Riordan

November 26, 2024

News Conference News PCR London Valves 2024

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

Michael O'Riordan

November 25, 2024

Presentation TCT 2024

TCT 1572: Navigating Narrow Paths: Valve-in-Valve TMVR in a Narrow LVOT

Presenter: Vijayadithyan Jaganathan

October 30, 2024

Presentation TCT 2024

Technical Enhancements and Case Vignettes from Second Generation TMVR Devices

Presenter: Pradeep Yadav

October 30, 2024

Presentation TCT 2024

A Critical Review of Clinical Results in Current TMVR Trials: Implications for Patient Selection and Study Design

Presenter: Firas Zahr

October 30, 2024

Presentation TCT 2024

ReValve

Presenter: Charles Davidson

October 29, 2024

Presentation TCT 2024

InnovHeart

Presenter: Torsten Vahl

October 29, 2024

Presentation TCT 2024

Tioga

Presenter: Edwin Ho

October 29, 2024

Presentation TCT 2024

The Intrepid TMVR Transseptal System: Technology and Clinical Updates

Presenter: Firas Zahr

October 29, 2024

Presentation TCT 2024

The MISCEND Study: Thirty-Day and One-Year Outcomes of TMVR With the Eos System

Presenter: Raj Makkar

October 29, 2024

Presentation TCT 2024

AltaValve TMVR System for Patients With Severe Mitral Regurgitation and Mitral Annular Calcification

Presenter: Tsuyoshi Kaneko

October 29, 2024

Presentation TCT 2024

Two-Year Outcomes Following Transseptal TMVR in the HighLife Feasibility Study: Hemodynamic Performance and Clinical Results

Presenter: Mirjam Keßler

October 29, 2024

Presentation TCT 2024

Primary Endpoint Results with the Second-Generation Cephea Transseptal TMVR System in Complex Mitral Valve Disease

Presenter: Pradeep Yadav

October 29, 2024

Presentation TCT 2024

Innovalve TMVR Facilitates LV Reverse Remodeling and Improvement in LV Function in Patients with Severe Mitral Regurgitation: Acute Results of the Innovalve TMVR TWIST-EFS and OUS Studies

Presenter: Steven Yakubov

October 29, 2024

Presentation TCT 2024

Reconciling Device Design and Clinical Need: How to Make TMVr Procedures Scalable and Reproducible?

Presenter: David Meerkin

October 29, 2024

Advertisement

Novel TMVR Devices: CAPSTAN Medical

Luna™ TMVR: Novel 28 French Transseptal TMVR System

Investigational Transeptal TMVR: SAPIEN M3

TMVR and the Tendyne roll-in and MAC experience

Preventing LVOT Obstruction during TMVR: Septal reduction and LAMPOON-What does the data say?

Residual TR After Treating Mitral ViV Disease Linked to Worse Outcomes

Live Valve Cases Safe, With Outcomes Comparable to Trials and Practice

TCT 1572: Navigating Narrow Paths: Valve-in-Valve TMVR in a Narrow LVOT

Technical Enhancements and Case Vignettes from Second Generation TMVR Devices

A Critical Review of Clinical Results in Current TMVR Trials: Implications for Patient Selection and Study Design

ReValve

InnovHeart

Tioga

The Intrepid TMVR Transseptal System: Technology and Clinical Updates

The MISCEND Study: Thirty-Day and One-Year Outcomes of TMVR With the Eos System

AltaValve TMVR System for Patients With Severe Mitral Regurgitation and Mitral Annular Calcification

Two-Year Outcomes Following Transseptal TMVR in the HighLife Feasibility Study: Hemodynamic Performance and Clinical Results

Primary Endpoint Results with the Second-Generation Cephea Transseptal TMVR System in Complex Mitral Valve Disease

Innovalve TMVR Facilitates LV Reverse Remodeling and Improvement in LV Function in Patients with Severe Mitral Regurgitation: Acute Results of the Innovalve TMVR TWIST-EFS and OUS Studies

Reconciling Device Design and Clinical Need: How to Make TMVr Procedures Scalable and Reproducible?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content